Michelle L M Mulder (Michelle Mulder)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Radical Prostatectomy

Palliative Care

Rheumatoid Arthritis Patients

Top Venues

Rheumatology (Oxford, England)

The Journal of rheumatology

Arthritis research & therapy

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Hanna J Johnsson, Gizem Ayan, Roxana Coras, Rachel Grynszpan, Sebastián Herrera, Hannah Jethwa, Dimitri Luz Felipe da Silva, Michelle L M Mulder, David Simon, Arani Vivekanantham, Leonieke J J van Mens, Fabian Proft
Young-GRAPPA 2023: The Future Is Bright. The Journal of rheumatology (2024)
Gizem Ayan, Roxana Coras, Rachel Grynszpan, Sebastián Herrera, Hannah Jethwa, Hanna J Johnsson, Leonieke J J van Mens, Michelle L M Mulder, David Simon, Arani Vivekanantham, Fabian Proft
Young-GRAPPA (Y-GRAPPA) at the GRAPPA 2022 Annual Meeting: One Year in Y-GRAPPA. Where Do We Stand, Where Do We Go? The Journal of rheumatology (2023)
Michelle L M Mulder, Anouk M Bertram, Mark H Wenink, Johanna E Vriezekolk
Defining the minimal important change (MIC) and meaningful change value (MCV) for the Psoriatic Arthritis Disease Activity Score (PASDAS) in a routine practice cohort of patients with psoriatic arthritis. Rheumatology (Oxford, England) 61 (10) (2022)
Michelle L M Mulder, Tamara W van Hal, Frank H J van den Hoogen, Elke M G J de Jong, Johanna E Vriezekolk, Mark H Wenink
Measuring disease activity in psoriatic arthritis: PASDAS implementation in a tightly monitored cohort reveals residual disease burden. Rheumatology (Oxford, England) 60 (7) (2021)
Michelle L M Mulder, Xuehui He, Juul M P A van den Reek, Paulo César Martins Urbano, Charlotte Kaffa, Xin-Hui Wang, Bram van Cranenbroek, Esther van Rijssen, Frank H J van den Hoogen, Irma Joosten, Wynand Alkema, Elke M G J de Jong, Ruben L Smeets, Mark H Wenink, Hans J P M Koenen
Blood-Based Immune Profiling Combined with Machine Learning Discriminates Psoriatic Arthritis from Psoriasis Patients. International journal of molecular sciences 22 (20) (2021)
Michelle L M Mulder, Tamara W van Hal, Mark H Wenink, Hans J P M Koenen, Frank H J van den Hoogen, Elke M G J de Jong, Juul M P A van den Reek, Johanna E Vriezekolk
Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review. Arthritis research & therapy 23 (1) (2021)
Michelle L M Mulder, Tamara W van Hal, Frank H J van den Hoogen, Elke M G J de Jong, Johanna E Vriezekolk, Mark H Wenink
Corrigendum to: Measuring disease activity in psoriatic arthritis: PASDAS implementation in a tightly monitored cohort reveals residual disease burden. Rheumatology (Oxford, England) (2021)
Michelle L M Mulder, Johanna E Vriezekolk, Nathan den Broeder, Elien A M Mahler, Philip S Helliwell, Frank H J van den Hoogen, Alfons A den Broeder, Mark H Wenink
Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA). Trials 21 (1) (2020)